Researchers Win $1.1M to Switch On Backup Copy of MECP2

Researchers Win $1.1M to Switch On Backup Copy of MECP2

296310

Researchers Win $1.1M to Switch On Backup Copy of MECP2

The Rett Syndrome Research Trust (RSRT) has given two researchers $1.1 million to collaborate on the development of a therapy capable of switching on a healthy, backup copy of MECP2 — the gene mutated in most cases of Rett syndrome. The collaboration involves Antonio Bedalov, MD, PhD, a professor at the Fred Hutchinson Cancer Research Center, in Washington, and Kyle Fink, PhD, a professor at the University of California, in Davis. Together, they plan to…

You must be logged in to read/download the full post.